QuidelOrtho Inc. (QDEL): Operatsion rentabellik

Ommaviy kompaniya Quidel Corporation (QDEL) logotipi

Operatsion marja tendentsiyasi QuidelOrtho (QDEL) kompaniyasining biznes barqarorligini tasdiqlaydi, bunda -2.40 baza parametr qiymati vazifasini o'taydi. Klassik laboratoriya testlari daromadning barqarorligini ta'minlaydi, Yevropa va AQShdagi zavodlar esa ishlab chiqarish ishonchliligini kafolatlaydi. Samaradorlik ekologik toza qadoqlarni joriy etish va CO2 emissiyalarini kamaytirish orqali qo'llab-quvvatlanmoqda. Ushbu grafik QuidelOrtho kompaniyasining joriy rentabelligini va o'sish potentsialini real vaqt rejimida baholash imkonini beradi.

QuidelOrtho Corporation (QDEL): Sotuvning operatsion rentabelligi 04.07.2022dan 19.11.2026gacha

QuidelOrtho (QDEL) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning fundamental baholanishi:QDEL, quidel.com
QuidelOrtho Inc. brendining mahsuloti

Ushbu ko'rsatkich moliyaviy xarajatlargacha bo'lgan daromad birligi uchun asosiy biznesdan foyda olish samaradorligini belgilaydi, bu esa investorga aktivning haqiqiy kapital intensivligini baholash imkonini beradi. Operatsion foyda marjalarining tahlili diagnostika sektoridagi pandemiyadan keyingi shiddatli raqobat sharoitida QuidelOrtho (QDEL) kompaniyasining yopiq uskunalar ekotizimi va maxsus reagentlar savdosi orqali yuqori marjalarni saqlab qolish qobiliyatini namoyish etadi.

QuidelOrtho raqobatchilari

Sotuvning operatsion marjasi A|DGX: Operatsion foyda normasi|Operatsion marja ILMN|EXAS (exactsciences.com) - Operatsion foyda normasi|Revvity Corp - Sotuvning operatsion marjasi|Operatsion foyda normasi BIO|Anbio Corp - Operatsion marja|Sotuvning operatsion rentabelligi Sterigenics|OPK (OPKO Corp) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha sotuv rentabelligi CDNA|MRVI (Maravai LifeSciences Holdings) - Operatsion marja|Sotuvning operatsion rentabelligi Fulgent Genetics Inc FLGT|Operatsion rentabellik fluidigm.com (LAB)|Sotuvning operatsion marjasi Cytek Bio CTKB|Operatsion marja OSUR (OraSure Technologies)|Operatsion foyda bo'yicha marjinallik Exagen Inc.|MDXH - Operatsion rentabellik|Operatsion faoliyat rentabelligi Lucid Diagnostics Inc LUCD|PRE: Operatsion marja|Insight Molecular (IMDX) - Operatsion marja|TRIB (trinitybiotech.com) - Operatsion marja|prophaselabs.com (PRPH) - Operatsion faoliyat rentabelligi|Operatsion marja AIMD|Operatsion faoliyat rentabelligi Co-Diagnostics Inc|Operatsion marja HSCS (Heart Test Laboratories, Inc.)|Operatsion foyda normasi BMRA|CDIO - Operatsion rentabellik|Sotuvning operatsion rentabelligi onconetix.gcs-web.com|Virax Biolabs Group (VRAX) - Operatsion rentabellik|BJDX - Operatsion faoliyat rentabelligi|AWH (Aspira Women's Health, Inc.) - Operatsion marja|Accelerate Diagnostics, Inc (AXDX) - Operatsion faoliyat rentabelligi|Operatsion marja CNTG|ENZ - Sotuvning operatsion rentabelligi|Operatsion foyda normasi Fresh2 Group Ltd|Genetic Technologies (GENE) - Sotuvning operatsion rentabelligi|ME - Operatsion rentabellik|Operatsion faoliyat rentabelligi Psychemedics Corp PMD